Heart Failure | CHOP Research Institute

Fueling the Heart: Frontier Program Seeks to Define and Treat Pediatric Heart Failure

Published on

Oct 6, 2023

Frontier Program Seeks to Define and Treat Pediatric Heart Failure

The Advanced Cardiac Therapies Frontier Program will find new solutions for treating heart failure in children.

CHOP Cardiovascular Institute

Harnessing the collective power of CHOP and Penn Medicine, CHOP Cardiovascular Institute will drive scientific discovery and medical breakthroughs that will improve pediatric cardiovascular care.

Dan Kelly Laboratory

The Kelly Lab is focused on deciphering the metabolic origins of disease toward novel therapeutic targets aimed at heart failure.

Daniel P. Kelly, MD

Dr. Kelly’s research career began with deciphering the genetic basis of inborn errors in metabolism in children, followed by a series of breakthrough discoveries relevant to the diagnosis and treatment of common forms of heart failure in the general population.

E-mail:

dankelly [at] pennmedicine.upenn.edu

Joseph W. Rossano, MD

Dr. Rossano's extensive research experience primarily involves the epidemiology and outcomes of cardiovascular disease in children, and multi-institutional collaborative observational and interventional studies. His particular research interests include evaluating the treatment and outcomes of pediatric cardiomyopathy, heart failure, and transplantation.

E-mail:

rossanoj [at] chop.edu

Brain Cancer Gene Therapy, 2019 Eagles Autism Challenge, Mitochondrial DNA in Cardiomyopathy, Kids First DRC, Device Symposium

Published on

Sep 21, 2018

in Cornerstone Blog

From novel findings about the role of mtDNA in heart disease to news about the 2nd Eagles Autism Challenge, we've got the latest headlines.